Cargando…

Dialysis outcomes in those aged ≥65 years

BACKGROUND: The number of elderly people over the age of 65 commencing dialysis in NZ has increased by almost 400% in the past decade. Few data are available about health related outcomes and survival on dialysis in the elderly to help the individual, their family, clinicians and health planners wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Robert, Derrett, Sarah, Campbell, John, Marshall, Mark R, Henderson, Andrew, Schollum, John, Williams, Sheila, McNoe, Bronwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765171/
https://www.ncbi.nlm.nih.gov/pubmed/23945009
http://dx.doi.org/10.1186/1471-2369-14-175
Descripción
Sumario:BACKGROUND: The number of elderly people over the age of 65 commencing dialysis in NZ has increased by almost 400% in the past decade. Few data are available about health related outcomes and survival on dialysis in the elderly to help the individual, their family, clinicians and health planners with decision-making. METHODS/DESIGN: This study will provide the first comprehensive longitudinal survey of health-related quality of life (HRQOL) and other patient centred outcomes for individuals aged ≥65 years on, or eligible for, dialysis therapy and will link these data to survival outcomes. Data collected by yearly structured interviews with participants will be linked to co-morbidity data, health service use, and laboratory information collected from health records, and analysed with respect to HRQOL and survival. The information obtained will inform the delivery of dialysis services in New Zealand and facilitate improved decision-making by individuals, their family and clinicians, about the appropriateness and impact of dialysis therapy on subsequent health and survival. DISCUSSION: Results from this study will make possible more informed decision-making by future elderly patients and their families as they contemplate renal replacement therapy. Results will also allow health professionals to more accurately describe the impact of dialysis therapy on quality of life and outcomes for patients. TRIAL REGISTRATION: ACTRN12611000024943.